Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

A new study from researchers in Japan has found a possible link between gum disease and multiple sclerosis , a condition that ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...

New Swedish research finds that people with highest microplastics and PFAS levels face double the risk of multiple sclerosis ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.